Cargando…
Vaccination with recombinant Toxoplasma gondii bradyzoite-formation deficient 1 (rTgBFD1) antigen provides partial protective immunity against chronic T. gondii infection
As an apicomplexan pathogen, Toxoplasma gondii still remains a major threat to public health and requires special attention. In fact, positive attempts to identify more effective antigens to provide protection are important to control toxoplasmosis. Latest scientific advances in T. gondii study hint...
Autores principales: | Tian, Xiaowei, Yang, Zhenke, Wan, Guangmin, Xie, Tong, Wang, Meng, Sun, Hanqi, Mei, Xuefang, Zhang, Zhenchao, Li, Xiangrui, Wang, Shuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510678/ https://www.ncbi.nlm.nih.gov/pubmed/36172608 http://dx.doi.org/10.3389/fvets.2022.957479 |
Ejemplares similares
-
A Novel Vaccine Candidate: Recombinant Toxoplasma gondii Perforin-Like Protein 2 Stimulates Partial Protective Immunity Against Toxoplasmosis
por: Tian, Xiaowei, et al.
Publicado: (2022) -
The determinants regulating Toxoplasma gondii bradyzoite development
por: Pan, Ming, et al.
Publicado: (2022) -
Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites
por: Murata, Yuho, et al.
Publicado: (2017) -
Acquisition of Host Cytosolic Protein by Toxoplasma gondii Bradyzoites
por: Kannan, Geetha, et al.
Publicado: (2021) -
Restriction Checkpoint Controls Bradyzoite Development in Toxoplasma gondii
por: Naumov, Anatoli V., et al.
Publicado: (2022)